These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 19127094

  • 1. A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature.
    Agarwalla PK, Dunn IF, Turner CD, Ligon KL, Schneider KA, Smith ER.
    Pediatr Neurosurg; 2008; 44(6):501-8. PubMed ID: 19127094
    [Abstract] [Full Text] [Related]

  • 2. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
    Salmon A, Amikam D, Sodha N, Davidson S, Basel-Vanagaite L, Eeles RA, Abeliovich D, Peretz T.
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079
    [Abstract] [Full Text] [Related]

  • 3. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
    Landolsi S, Gharbi O, Zrig M, Gribaa M, Njim L, Zakhama A, Abid A, Frébourg T, Ahmed SB.
    Ann Biol Clin (Paris); 2010 Sep; 68(3):346-50. PubMed ID: 20478780
    [Abstract] [Full Text] [Related]

  • 4. Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations.
    Krutilkova V, Trkova M, Fleitz J, Gregor V, Novotna K, Krepelova A, Sumerauer D, Kodet R, Siruckova S, Plevova P, Bendova S, Hedvicakova P, Foreman NK, Sedlacek Z.
    Eur J Cancer; 2005 Jul; 41(11):1597-603. PubMed ID: 15925506
    [Abstract] [Full Text] [Related]

  • 5. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C, Voigtländer T, Lübbert M.
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
    [Abstract] [Full Text] [Related]

  • 6. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
    Manoukian S, Peissel B, Pensotti V, Barile M, Cortesi L, Stacchiotti S, Terenziani M, Barbera F, Pasquini G, Frigerio S, Pierotti MA, Radice P, Della-Torre G.
    Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268
    [Abstract] [Full Text] [Related]

  • 7. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [Abstract] [Full Text] [Related]

  • 8. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
    Bendig I, Mohr N, Kramer F, Weber BH.
    Cancer Genet Cytogenet; 2004 Oct 01; 154(1):22-6. PubMed ID: 15381368
    [Abstract] [Full Text] [Related]

  • 9. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A, Vazna A, Hrachovina O, Bendova S, Prochazkova K, Sedlacek Z.
    Cancer Genet Cytogenet; 2009 Aug 01; 193(1):63-6. PubMed ID: 19602465
    [Abstract] [Full Text] [Related]

  • 10. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J, Selistre SG, Rossi C, Alemar B, Santos-Silva P, Pereira FS, Netto CB, Cossio SL, Roth DE, Brunetto AL, Zagonel-Oliveira M, Martel-Planche G, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P.
    Cancer; 2013 Dec 15; 119(24):4341-9. PubMed ID: 24122735
    [Abstract] [Full Text] [Related]

  • 11. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome.
    Rieber J, Remke M, Hartmann C, Korshunov A, Burkhardt B, Sturm D, Mechtersheimer G, Wittmann A, Greil J, Blattmann C, Witt O, Behnisch W, Halatsch ME, Orakcioglu B, von Deimling A, Lichter P, Kulozik A, Pfister S.
    Genes Chromosomes Cancer; 2009 Jul 15; 48(7):558-68. PubMed ID: 19378321
    [Abstract] [Full Text] [Related]

  • 12. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM.
    Cancer Res; 1997 Aug 01; 57(15):3245-52. PubMed ID: 9242456
    [Abstract] [Full Text] [Related]

  • 13. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL.
    Oncogene; 2001 Jul 27; 20(33):4441-9. PubMed ID: 11494139
    [Abstract] [Full Text] [Related]

  • 14. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN.
    J Clin Oncol; 2009 Mar 10; 27(8):1250-6. PubMed ID: 19204208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA.
    Cancer Res; 2003 Oct 15; 63(20):6643-50. PubMed ID: 14583457
    [Abstract] [Full Text] [Related]

  • 17. De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system.
    Schniederjan MJ, Shehata B, Brat DJ, Esiashvili N, Janss AJ.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1352-4. PubMed ID: 19711436
    [Abstract] [Full Text] [Related]

  • 18. Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation.
    Rossbach HC, Baschinsky D, Wynn T, Obzut D, Sutcliffe M, Tebbi C.
    Pediatr Blood Cancer; 2008 Mar 15; 50(3):681-3. PubMed ID: 17427234
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
    Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N, Hawkins C, Bouffet E, Pienkowska M, Lafay-Cousin L, Gozali A, Zhukova N, Shane L, Gonzalez I, Finlay J, Malkin D.
    J Clin Oncol; 2010 Apr 20; 28(12):1995-2001. PubMed ID: 20308654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.